130 related articles for article (PubMed ID: 31258081)
1. Anti-VEGFR2 Antibody-modified Micelle for Triggered Drug Delivery and Effective Therapy of Choroidal Neovascularization.
Takahashi K; Masuda T; Harada M; Inoue T; Nakamura S; Naito K; Hara H; Shimazawa M
Curr Neurovasc Res; 2019; 16(3):258-265. PubMed ID: 31258081
[TBL] [Abstract][Full Text] [Related]
2. Apatinib, an Inhibitor of Vascular Endothelial Growth Factor Receptor 2, Suppresses Pathologic Ocular Neovascularization in Mice.
Kim KL; Suh W
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3592-3599. PubMed ID: 28715845
[TBL] [Abstract][Full Text] [Related]
3. Intravitreal Stanniocalcin-1 Enhances New Blood Vessel Growth in a Rat Model of Laser-Induced Choroidal Neovascularization.
Zhao M; Xie W; Tsai SH; Hein TW; Rocke BA; Kuo L; Rosa RH
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1125-1133. PubMed ID: 29490350
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal itraconazole inhibits laser-induced choroidal neovascularization in rats.
Bae JH; Hwang AR; Kim CY; Yu HG; Koh HJ; Yang WI; Chang HR; Lee SC
PLoS One; 2017; 12(6):e0180482. PubMed ID: 28666022
[TBL] [Abstract][Full Text] [Related]
5. Activated protein C induces suppression and regression of choroidal neovascularization- A murine model.
Livnat T; Weinberger Y; Budnik I; Deitch I; Dahbash M; Sella R; Dardik R; Kenet G; Nisgav Y; Weinberger D
Exp Eye Res; 2019 Sep; 186():107695. PubMed ID: 31201804
[TBL] [Abstract][Full Text] [Related]
6. Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344.
Xie P; Kamei M; Suzuki M; Matsumura N; Nishida K; Sakimoto S; Sakaguchi H; Nishida K
PLoS One; 2011; 6(12):e28933. PubMed ID: 22205983
[TBL] [Abstract][Full Text] [Related]
7. Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression Alone.
Ma J; Sun Y; López FJ; Adamson P; Kurali E; Lashkari K
Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3138-44. PubMed ID: 27304845
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
Gu L; Chen H; Tuo J; Gao X; Chen L
Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
[TBL] [Abstract][Full Text] [Related]
9. VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.
Huang H; Parlier R; Shen JK; Lutty GA; Vinores SA
PLoS One; 2013; 8(8):e71808. PubMed ID: 23977149
[TBL] [Abstract][Full Text] [Related]
10. Suppression of choroidal neovascularization and quantitative and qualitative inhibition of VEGF and CCL2 by heparin.
Tomida D; Nishiguchi KM; Kataoka K; Yasuma TR; Iwata E; Uetani R; Kachi S; Terasaki H
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3193-9. PubMed ID: 21296829
[TBL] [Abstract][Full Text] [Related]
11. Serine racemase deficiency attenuates choroidal neovascularization and reduces nitric oxide and VEGF levels by retinal pigment epithelial cells.
Jiang H; Wu M; Liu Y; Song L; Li S; Wang X; Zhang YF; Fang J; Wu S
J Neurochem; 2017 Nov; 143(3):375-388. PubMed ID: 28892569
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of choroidal neovascularization by histone deacetylase inhibitor.
Chan N; He S; Spee CK; Ishikawa K; Hinton DR
PLoS One; 2015; 10(3):e0120587. PubMed ID: 25807249
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal tanibirumab, a fully human monoclonal antibody against vascular endothelial growth factor receptor 2, partially suppresses and regresses laser-induced choroidal neovascularization in a rat model.
Kim J; Kim TE; Kim JA; Yun JH; Sohn S; Shim SR; Lee SH; Kim SJ
J Ocul Pharmacol Ther; 2014 Dec; 30(10):847-53. PubMed ID: 25188901
[TBL] [Abstract][Full Text] [Related]
14. Edaravone is a free radical scavenger that protects against laser-induced choroidal neovascularization in mice and common marmosets.
Masuda T; Shimazawa M; Takata S; Nakamura S; Tsuruma K; Hara H
Exp Eye Res; 2016 May; 146():196-205. PubMed ID: 27018216
[TBL] [Abstract][Full Text] [Related]
15. Baicalin attenuates laser-induced choroidal neovascularization.
Yang SJ; Jo H; Kim JG; Jung SH
Curr Eye Res; 2014 Jul; 39(7):745-51. PubMed ID: 24502359
[TBL] [Abstract][Full Text] [Related]
16. Topical Diclofenac-Loaded Liposomes Ameliorate Laser-Induced Choroidal Neovascularization in Mice and Non-Human Primates.
Shimazawa M; Inoue Y; Masuda T; Onodera R; Tahara K; Shimizu Y; Mibe Y; Tsuruma K; Takeuchi H; Hara H
Curr Neurovasc Res; 2017; 14(1):46-52. PubMed ID: 27823554
[TBL] [Abstract][Full Text] [Related]
17. [Novel approach for management of age-related macular degeneration--antiangiogenic therapy and retinal regenerative therapy].
Tamaki Y
Nippon Ganka Gakkai Zasshi; 2007 Mar; 111(3):232-68; discussion 269. PubMed ID: 17402564
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia specific SDF-1 expression by retinal pigment epithelium initiates bone marrow-derived cells to participate in Choroidal neovascularization in a laser-induced mouse model.
Zhang ZX; Wang YS; Shi YY; Hou HY; Zhang C; Cai Y; Dou GR; Yao LB; Li FY
Curr Eye Res; 2011 Sep; 36(9):838-49. PubMed ID: 21851170
[TBL] [Abstract][Full Text] [Related]
19. Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye.
Huang H; Shen J; Vinores SA
PLoS One; 2011; 6(6):e21411. PubMed ID: 21731737
[TBL] [Abstract][Full Text] [Related]
20. Repeated retinal photocoagulation in monkeys for the optimization of a laser-induced choroidal neovascularization model.
Lin X; Wang Q; He M
Exp Eye Res; 2019 Jul; 184():1-7. PubMed ID: 30928489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
